Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3476
Clean Energy Fuels
CLNE
$344M
| $737K | ﹤0.01% |
377,905
+101,741
| +37% | +$173K |
2013 Q2
48 quarters
|
|
3477
PUT
ASP Isotopes
ASPI
$448M
| $736K | ﹤0.01% |
+100,000
| New | +$671K |
2025 Q2
0 quarters
|
|
3478
AngioDynamics
ANGO
$655M
| $733K | ﹤0.01% |
73,905
+34,966
| +90% | +$342K |
2013 Q2
48 quarters
|
|
|
DHIL
3479
DELISTED
Diamond Hill
DHIL
| $733K | ﹤0.01% |
5,044
+1,905
| +61% | +$262K |
2019 Q1
25 quarters
|
|
3480
Delcath Systems
DCTH
$552M
| $731K | ﹤0.01% |
53,783
+3,118
| +6% | +$43.5K |
2024 Q3
3 quarters
|
|
|
SKYT
3481
DELISTED
SkyWater Technology
SKYT
| $731K | ﹤0.01% |
74,323
+16,681
| +29% | +$135K |
2022 Q1
13 quarters
|
|
3482
Allogene Therapeutics
ALLO
$515M
| $729K | ﹤0.01% |
645,325
-10,066
| -2% | -$13.4K |
2018 Q4
26 quarters
|
|
3483
TETRA Technologies
TTI
$893M
| $727K | ﹤0.01% |
216,390
+51,564
| +31% | +$150K |
2021 Q1
17 quarters
|
|
3484
Third Coast Bancshares
TCBX
$716M
| $725K | ﹤0.01% |
22,203
+10,047
| +83% | +$306K |
2022 Q1
13 quarters
|
|
3485
Teekay
TK
$1.31B
| $725K | ﹤0.01% |
87,883
+32,598
| +59% | +$253K |
2013 Q4
46 quarters
|
|
|
PWOD
3486
DELISTED
Penns Woods Bancorp
PWOD
| $722K | ﹤0.01% |
23,778
+12,055
| +103% | +$346K |
2016 Q1
37 quarters
|
|
3487
Trump Media & Technology Group
DJT
$2.44B
| $720K | ﹤0.01% |
39,918
+17,997
| +82% | +$392K |
2022 Q1
13 quarters
|
|
3488
Atlanta Braves Holdings Series A
BATRA
$3.7B
| $718K | ﹤0.01% |
14,585
+1,965
| +16% | +$86.9K |
2023 Q4
6 quarters
|
|
|
SHYF
3489
DELISTED
The Shyft Group
SHYF
| $717K | ﹤0.01% |
57,172
+20,761
| +57% | +$203K |
2022 Q1
13 quarters
|
|
3490
Arrow Financial
AROW
$695M
| $715K | ﹤0.01% |
27,060
+10,589
| +64% | +$270K |
2016 Q1
37 quarters
|
|
3491
AerSale
ASLE
$237M
| $714K | ﹤0.01% |
118,769
+76,677
| +182% | +$491K |
2022 Q1
13 quarters
|
|
3492
PUT
DaVita
DVA
$11.4B
| $712K | ﹤0.01% |
5,000
| – | – |
2024 Q3
3 quarters
|
|
3493
Timberland Bancorp
TSBK
$352M
| $710K | ﹤0.01% |
22,757
+5,376
| +31% | +$164K |
2022 Q3
11 quarters
|
|
3494
CALL
Leidos
LDOS
$15B
| $710K | ﹤0.01% |
+4,500
| New | +$665K |
2025 Q2
0 quarters
|
|
3495
Tango Therapeutics
TNGX
$3.88B
| $710K | ﹤0.01% |
138,650
+75,618
| +120% | +$187K |
2022 Q1
13 quarters
|
|
3496
SelectQuote
SLQT
$75.7M
| $709K | ﹤0.01% |
298,053
+125,154
| +72% | +$329K |
2022 Q1
13 quarters
|
|
|
TRML
3497
DELISTED
Tourmaline Bio
TRML
| $709K | ﹤0.01% |
44,341
+12,546
| +39% | +$203K |
2022 Q1
13 quarters
|
|
3498
Invesco China Technology ETF
CQQQ
$2.54B
| $708K | ﹤0.01% |
16,000
| – | – |
2024 Q2
4 quarters
|
|
3499
MINISO
MNSO
$2.6B
| $708K | ﹤0.01% |
+38,837
| New | +$698K |
2025 Q2
0 quarters
|
|
3500
Pulmonx
LUNG
$80.7M
| $706K | ﹤0.01% |
272,646
+168,441
| +162% | +$664K |
2022 Q1
13 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.